7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Carcinoma, Medullary D018276 2 associated lipids
Periapical Granuloma D010484 3 associated lipids
Respirovirus Infections D010253 3 associated lipids
Osteitis Deformans D010001 3 associated lipids
Measles D008457 3 associated lipids
Malocclusion D008310 3 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Zhou QL et al. Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. 2016 Mol Med Rep pmid:27357904
Lin J et al. Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. 2016 Nat Commun pmid:26923114
D'Abramo A et al. Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. 2016 PLoS ONE pmid:26913505
Lu J et al. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. 2016 Exp. Biol. Med. (Maywood) pmid:26908571
Theodoro LH et al. Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. 2016 J. Periodont. Res. pmid:26750739
Mitchell JA et al. Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. 2016 J. Bone Miner. Res. pmid:26572781
Toffoli B et al. Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. 2016 Mediators Inflamm. pmid:28070143
Chen H et al. [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. 2016 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:28070039
Nagy EE et al. High circulating osteoprotegerin levels are associated with non-zero blood groups. 2016 BMC Cardiovasc Disord pmid:27387019
Zhang YY et al. Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. 2016 Chin J Dent Res pmid:27379348

Table of Content